Lundbeck
HLUN-B.CO
#2785
Rank
A$8.99 B
Marketcap
A$9.07
Share price
0.14%
Change (1 day)
-3.01%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): A$1.13

According to Lundbeck's latest financial reports the company's current EPS (TTM) is A$1.04. In 2025 the company made an earnings per share (EPS) of A$0.70 an increase over its 2024 EPS that were of A$0.61.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.1360.99%
2025A$0.7014.5%
2024A$0.6129.29%
2023A$0.4823.09%
2022A$0.3937.26%
2021A$0.28-84.61%
2020A$1.83-24.61%
2019A$2.43-42.06%
2018A$4.1940.7%
2017A$2.98146.26%
2016A$1.21-120.48%
2015A-$5.903231.32%
2014A-$0.18-115.78%
2013A$1.12-23.36%
2012A$1.46-48.01%
2011A$2.82-9.68%
2010A$3.1213.72%
2009A$2.7424.32%
2008A$2.21-6.05%
2007A$2.3581.77%
2006A$1.29-16.76%
2005A$1.55-17.58%
2004A$1.88